Overview
Portfolio
More
Lifeforce Capital
Lifeforce Capital invests in software companies reshaping the status quo in healthcare’s largest markets. They focus on firms that advance care delivery through new technologies, care models, and software‑first computati...
Portfolio
50+
Employees
5+
Founded
2015
AUM
≈ $146.0M
Investment focus
Stages
No stages listed
Industries
Software OnlyHealthcare Technology
Fund details
Funds
Lifeforce Lifecycle VII LLC
Vintage 2025 • $0.7
Lifeforce Lifecycle III LLC
Vintage 2023 • $2.5
Lifeforce Lifecycle IV LLC
Vintage 2023 • $0.3
Lifeforce Lifecycle V LLC
Vintage 2023 • $1.8
Lifeforce Capital Ivy LLC
Vintage 2022 • $8.0
Lifeforce Lifecycle I LLC
Vintage 2022 • $5.8
Lifeforce Capital Fund II LP
Vintage 2020 • $45.6
Lifeforce Capital Fund I LP
Vintage 2020 • $21.1
Lifeforce Lifecycle II LLC
Vintage 2022 • $0.0
Lifeforce 1 Life Healthcare Secondary LLC
Vintage 2020 • $0.0
Sources
Lifeforce Capital
Lifeforce Capital invests in software companies reshaping the status quo in healthcare’s largest markets. They focus on firms that advance care delivery through new technologies, care models, and software‑first computational drug discovery platforms.
Portfolio
50+
Employees
5+
Founded
2015
AUM
≈ $146.0M
Funds
Lifeforce Lifecycle VII LLC · Vintage 2025 • $0.7
Lifeforce Lifecycle III LLC · Vintage 2023 • $2.5
Lifeforce Lifecycle IV LLC · Vintage 2023 • $0.3
Lifeforce Lifecycle V LLC · Vintage 2023 • $1.8
Lifeforce Capital Ivy LLC · Vintage 2022 • $8.0
Lifeforce Lifecycle I LLC · Vintage 2022 • $5.8
Lifeforce Capital Fund II LP · Vintage 2020 • $45.6
Lifeforce Capital Fund I LP · Vintage 2020 • $21.1
Lifeforce Lifecycle II LLC · Vintage 2022 • $0.0
Lifeforce 1 Life Healthcare Secondary LLC · Vintage 2020 • $0.0
Stages
No stages listed
Industries
Software OnlyHealthcare Technology
Sources
Showing 24 of 46 matched portfolio companies
64x Bio develops a high throughput genome engineering platform that accelerates the discovery of optimized mammalian cell lines for cell and gene therapies. This technology enables pharmaceutical and biotechnology companies to efficiently design and manufacture next-generation therapeutics, addressing the challenges of traditional cell line development.
Funding: $59.5M
Rough estimate of the amount of funding raised
Funding: $59.5M
Rough estimate of the amount of funding raised
Able Health offers cloud-based clinical analytics accelerators and expert services that utilize integrated patient data to identify care variation and prioritize improvement opportunities. The platform enables healthcare organizations to streamline clinical registry development and data management, resulting in measurable reductions in costs and improved patient outcomes.
Funding: $18.0M
Rough estimate of the amount of funding raised
Funding: $18.0M
Rough estimate of the amount of funding raised
Advantia Health provides an integrated network of women’s health specialties—including obstetrics, gynecology, maternal‑fetal medicine, mental‑health, and urgent care—delivered through a unified electronic health record and patient portal. The platform enables coordinated appointments, secure messaging, telemedicine visits, and automated insurance billing to streamline care for reproductive‑age women and their providers.
Funding: $5.0M
Rough estimate of the amount of funding raised
Funding: $5.0M
Rough estimate of the amount of funding raised
Aspen Neuroscience develops autologous induced pluripotent stem cell (iPSC)-derived neuron replacement therapy specifically for Parkinson's disease, utilizing advanced stem cell biology and genomics. This approach addresses the degeneration of neurons in patients, aiming to restore lost function and improve quality of life.
Funding: $224.0M
Rough estimate of the amount of funding raised
Funding: $224.0M
Rough estimate of the amount of funding raised
Bayesian Health provides an adaptive AI platform that delivers real-time clinical insights to healthcare providers, enabling early detection of life-threatening events. This technology organizes and analyzes healthcare data to enhance patient outcomes and reduce mortality rates.
Funding: $40.0M
Rough estimate of the amount of funding raised
Funding: $40.0M
Rough estimate of the amount of funding raised
The startup offers an AI-powered skincare platform that utilizes machine learning algorithms to assess over a thousand skin conditions, including skin cancer and autoimmune disorders. By providing detailed prevalence and severity scores for conditions like acne, psoriasis, and eczema, the platform enables users to gain actionable insights into their skin health.
Funding: $7.5M
Rough estimate of the amount of funding raised
Funding: $7.5M
Rough estimate of the amount of funding raised
Carecubes provides a modular, FDA‑cleared isolation enclosure that converts a standard hospital bed into a negative‑pressure airborne infection isolation room within minutes. The system delivers ≥12 air changes per hour with integrated HEPA filtration, enabling bedside care while reducing PPE use and expanding isolation capacity for hospitals, clinics, and field medical units.
5+
200+Approximate amount of employees
Carelon Palliative Care provides 24/7 multidisciplinary palliative services that combine in‑home and virtual visits to manage symptoms, advance care planning, and caregiver support for patients with serious or chronic illnesses. Care plans are recorded in secure EHRs and shared via HL7/FHIR APIs, enabling real‑time coordination with primary physicians and health‑plan partners to reduce hospitalizations.
1000+
50K+Approximate amount of employees
Character is a precision medicine company focused on macular degeneration and primary open-angle glaucoma, utilizing clinical genomic databases and machine learning to identify genetic drivers of disease progression. By characterizing patient subtypes, Character aims to develop targeted therapies for conditions that currently have limited treatment options.
Funding: $24.0M
Rough estimate of the amount of funding raised
Funding: $24.0M
Rough estimate of the amount of funding raised
Circle Pharma designs and develops bioavailable macrocyclic peptide therapeutics targeting intracellular protein-protein interactions, particularly those involved in cancer. Their computational structure-based design approach combines physics-based conformational modeling and innovative chemistry to create permeable macrocyclic peptide drug candidates.
Funding: $90.0M
Rough estimate of the amount of funding raised
The Column Group
The Column Group
Funding: $90.0M
Rough estimate of the amount of funding raised
Cityblock provides personalized, prevention-oriented healthcare and social services to underserved communities through a technology-driven model that integrates care coordination and communication. By addressing gaps in access to primary care, mental health support, and social resources, Cityblock aims to improve health outcomes and reduce costs for low-income populations.
Funding: $886.0M
Rough estimate of the amount of funding raised
Funding: $886.0M
Rough estimate of the amount of funding raised
Crickethealth offers an integrated, value‑based kidney‑care platform that connects nephrology physicians, dialysis providers, payers, and patients across the United States. Leveraging a nationwide network of 2,200+ physician partners, virtual care teams in all 50 states, and predictive analytics, the platform streamlines referrals, boosts home‑dialysis start rates, and reduces hospitalizations through coordinated care pathways and real‑time outcome monitoring.
Cylinder Health provides a virtual, clinician‑backed platform for digestive health that combines at‑home microbiome testing with personalized care plans from gastroenterologists, dietitians, and health coaches. Members receive digital therapeutics, diet and lifestyle guidance, symptom tracking, and 24/7 support through a secure web and mobile interface, enabling comprehensive GI care without in‑person visits.
Funding: $31.0M
Rough estimate of the amount of funding raised
+ 5 Other investorsMercato Partners
+ 5 Other investorsMercato Partners
Funding: $31.0M
Rough estimate of the amount of funding raised
Dr Consulta operates a network of multi‑specialty clinics that combine primary care, specialist consultations and on‑site diagnostics in a single location. Patients book same‑day appointments through a mobile app or web portal, receive care coordinated through an integrated electronic medical record, and pay transparent flat‑rate fees that are compatible with insurers and corporate health plans. The model reduces wait times, administrative overhead and out‑of‑pocket cost variability for urban individuals, families, employers and insurers.
Funding: $10.0M
Rough estimate of the amount of funding raised
Funding: $10.0M
Rough estimate of the amount of funding raised
Dr. Katz offers an AI-powered, clinician-informed platform designed to support both mental health patients and providers within health systems. This technology personalizes care delivery, significantly reduces administrative burden, and helps generate revenue. The platform facilitates holistic care by integrating behavioral health into primary care settings using Collaborative Care models.
Enveda Biosciences utilizes a platform that rapidly purifies and characterizes natural molecules, enabling the discovery of new drugs at four times the industry average speed. By unlocking the chemical potential of the vast majority of the natural world, Enveda addresses the challenge of slow and costly drug development processes.
Founded 2019
Fathom offers an AI-powered medical coding automation platform that can process millions of charts daily with over 90% accuracy, significantly reducing coding costs by up to 50%. The platform addresses staffing challenges and accelerates coding turnaround times, ensuring reliable and secure operations for healthcare providers.
Funding: $60.1M
Rough estimate of the amount of funding raised
Alkeon CapitalLightspeed Venture Partners
Alkeon CapitalLightspeed Venture Partners
Funding: $60.1M
Rough estimate of the amount of funding raised
Fauna Bio utilizes an AI-driven platform, Convergence™, to analyze genetic data from diverse mammalian species, enabling the discovery of novel therapeutic targets for age-related diseases and metabolic disorders. By replicating the natural disease resistance mechanisms found in these animals, the company aims to develop effective drugs that can improve human health outcomes.
Funding: $53.1M
Rough estimate of the amount of funding raised
Funding: $53.1M
Rough estimate of the amount of funding raised
Floreo provides a virtual‑reality therapy platform that delivers research‑backed social‑skill lessons for neurodiverse learners of any age. Accessible via smartphone‑plus‑cardboard or standalone VR headsets, the system offers immersive, repeatable practice, real‑time coaching, and cloud‑based analytics that integrate with telehealth workflows, enabling clinicians, schools, and families to deliver scalable, evidence‑based skill training.
Galileo offers a health assistance mobile application that connects users with a dedicated team of clinicians for 24/7 access to primary and specialty care, utilizing a voice, video, and chat-enabled platform. The application addresses the challenges of poor access and high costs in traditional healthcare by providing proactive, coordinated care that has demonstrated an 11.5% reduction in total healthcare costs within six months.
HeartFlow provides a non-invasive cardiac test that utilizes advanced medical imaging and artificial intelligence to visualize coronary arteries, enabling precise assessment of plaque and lesion-specific fractional flow reserve (FFR). This technology allows physicians to develop effective treatment plans for cardiovascular disease without the risks and costs associated with invasive procedures.
Funding: $215.0M
Rough estimate of the amount of funding raised
Bain Capital Life Sciences
Bain Capital Life Sciences
Funding: $215.0M
Rough estimate of the amount of funding raised
Included Health provides personalized virtual care and navigation services to members through employers and health plans. The platform integrates primary, specialty, and behavioral health care with administrative support for billing and claims advocacy. This comprehensive approach aims to simplify the healthcare experience and connect individuals with high-quality, coordinated medical resources.
Funding: $175.0M
Rough estimate of the amount of funding raised
The Carlyle Group
The Carlyle Group
Funding: $175.0M
Rough estimate of the amount of funding raised
MindRight Health provides culturally-responsive mental health coaching via text messaging, offering daily support from a dedicated team of coaches to youth and young adults facing stress and trauma. The platform addresses the lack of accessible, nonclinical mental health resources for communities of color and low-income families, enabling proactive engagement to prevent crises and promote emotional well-being.
Funding: $3.1M
Rough estimate of the amount of funding raised
ICONIQ Capital
ICONIQ Capital
Funding: $3.1M
Rough estimate of the amount of funding raised
Mythic Therapeutics develops FateControl™ technology to enhance the efficacy of antibody-drug conjugates (ADCs) by increasing their uptake in cancer cells while preventing payload release in healthy tissues. This approach significantly improves treatment outcomes for a wider range of cancer types by reducing toxicity and side effects associated with traditional chemotherapy delivery methods.
Funding: $156.5M
Rough estimate of the amount of funding raised
Viking Global Investors
Viking Global Investors
Funding: $156.5M
Rough estimate of the amount of funding raised
Showing 4 of 4 unmatched portfolio companies